Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Olivier De Wever
Profile
Projects
Publications
Activities
Awards & Distinctions
Results
:
ALL
(
60
)
Order By :
Title (a-z)
Title (a-z)
Chronological by starting year (new to old)
As
Promotor-spokesperson
01 February 2024 → 31 January 2027
Cofunding Core Facility - Clinical Tissue and Cell Culture core
Funding: Regional and community funding: Special Research Fund
As
Promotor
01 October 2018 → 30 September 2019
beurs EVDS Arne Peirsman: Design of a 3D printed and perfused breast cancer metastasis model (3D PAP Be CAME model)
Fellow: Arne Peirsman
Funding: Funding by bilateral agreement (private and foundations)
01 October 2015 → 30 September 2016
Beurs Joke Tommelein: Radiotherapy-induced damage to cancer-associated fibroblasts promotes colorectal cancer progression through IGF-1/AKT signaling
Fellow: Joke Tommelein
Funding: Research Foundation - Flanders (FWO)
01 February 2015 → 31 January 2020
BOF-ZAP professorship in cancer research
Fellows: Olivier De Wever
Funding: Regional and community funding: Special Research Fund
01 October 2012 → 30 September 2016
Cancer Associated Fibroblasts (CAF) Function in Tumor Expansion and Invasion
Funding: European funding: framework programme
01 October 2016 → 30 September 2017
Can the Rnome, encapsulated in extracellular vesicles, assist in directing therapy in patients with metastatic Castration Resistant Prostate Cancer
Fellow: Bert Dhondt
Funding: Funding by bilateral agreement (private and foundations)
01 February 2024 → 31 January 2027
Cofunding Core Facility - Patient-derived xenograft models
Funding: Regional and community funding: Special Research Fund
01 January 2016 → 31 December 2019
Design and evaluation of a traceable reference material for extracellular vesicles
Fellows: Edward Geeurickx
Funding: Research Foundation - Flanders (FWO)
15 December 2022 → 14 December 2024
Evaluation of cellular dynamics using automated widefield imaging
Funding: Regional and community funding: Special Research Fund
01 January 2016 → 31 December 2018
Exosomal miRNAs as a biomarker for early targeted therapy response in advanced triple negative breast cancer
Funding: Research Foundation - Flanders (FWO)
01 January 2015 → 31 December 2021
Exosomes: customized messengers tumor ecosystems.
Funding: Research Foundation - Flanders (FWO)
01 January 2018 → 31 December 2022
Extracellullar vesicle signatures as biomarker of therapeutic efficiency in metastatic breast cancer
Funding: Funding by bilateral agreement (private and foundations)
01 October 2011 → 31 December 2016
Fibrosis-related biomarkers and therapeutic targets for radiation-induced anorectal dysfunction
Funding: Funding by bilateral agreement (private and foundations)
01 November 2020 → 31 October 2024
Identification of Low-Grade Serous Ovarian Carcinoma (LGSOC) therapeutics using clinical relevant spheroid and tumor-engineered models for peritoneal metastasis.
Fellow: Eva Blondeel
Funding: Research Foundation - Flanders (FWO)
01 January 2016 → 31 December 2019
Identification of recombinant nanobodies for exosome immunecapture in breast cancer diagnosis
Funding: Research Foundation - Flanders (FWO)
01 August 2017 → 30 November 2022
INnovative Flemish IN vivo Imaging TechnologY (INFINITY)
Funding: Regional and community funding: Special Research Fund
01 December 2020 → 30 November 2022
IVIS Lumina III LT In Vivo imaging system.
Funding: Regional and community funding: Special Research Fund
01 June 2015 → 31 May 2017
Longitudinal imaging of cellular dynamics with a biostation IM-Q (microscope with sensitive CCD camera and integrated incubator)
Funding: Regional and community funding: Special Research Fund
15 April 2024 → 14 April 2026
METAstasis in the Lab: quantification and validation of a new approach method to test therapeutics targeting metastasis
Funding: Regional and community funding: Industrial Research Fund
01 January 2013 → 30 June 2015
Microparticle-encapsulated tumor-environment interactions to capture disseminated mesothelioma cells
Funding: Funding by bilateral agreement (private and foundations)
01 October 2013 → 30 September 2014
Myosin II as a central regulator of exosome-related communications in the tumor environment
Funding: Funding by bilateral agreement (private and foundations)
01 October 2018 → 30 September 2022
Plasma-activated liquids: an innovative method to treat cancer
Funding: Regional and community funding: Special Research Fund
01 October 2011 → 30 September 2013
primary vs secondary resistance to EGFR-targeted therapy in colorectal cancer: biological and predictive significance of stromal-derived neuregulin-1
Funding: Funding by bilateral agreement (private and foundations)
01 January 2011 → 31 October 2015
Pro-invasive response of tumor-associated myofibroblasts to radiation therapy
Funding: Regional and community funding: Special Research Fund
01 January 2011 → 30 June 2015
Rab27B-mediated pre-metastatic niche formation: possible therapeutic opportunities
Funding: Funding by bilateral agreement (private and foundations)
01 October 2018 → 30 September 2022
Targeting cancer-associated fibroblasts to overcome immunosuppressive mechanisms in mismatch repair-deficient tumors
Fellow: Emiel De Jaeghere
Funding: Research Foundation - Flanders (FWO)
01 January 2015 → 31 December 2018
Targeting of early metastic lesions by exosome-mimetic nanoparticles
Funding: Research Foundation - Flanders (FWO)
01 January 2021 → 31 December 2024
Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases
Funding: Regional and community funding: Special Research Fund
01 October 2020 → 30 September 2024
Targeting tumor microenvironment to counteract cancer progression
Funding: Regional and community funding: Special Research Fund
01 January 2013 → 31 October 2019
The metastic niche: preparation, function and translational evidence of a permissieve micro environment for cancer dissemination
Funding: Regional and community funding: Special Research Fund
01 October 2015 → 30 September 2019
Therapeutic targeting of early metastasis by exosome-mimetic gold nanoparticles
Fellows: Jan Van Deun
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2017
The tumor-ecosystem: a source of therapeutic targets and prognostic biomarkers
Funding: Funding by bilateral agreement (private and foundations)
15 December 2022 → 14 December 2024
Tissue and cell culture core facility
Funding: Regional and community funding: Special Research Fund
15 October 2016 → 14 April 2018
Traceable reference standard for extracellular vesicles
Funding: Regional and community funding: Industrial Research Fund
01 October 2018 → 30 September 2021
Tumor engineering a clinical relevant in vivo model for peritoneal metastasis
Fellow: Elly De Vlieghere
Funding: Research Foundation - Flanders (FWO)
15 April 2015 → 14 October 2016
Use of the small GTPase Rab27b to diagnose and treat poor prognosis estrogen-receptor-positive (ER+) breast cancer
Funding: Regional and community funding: Industrial Research Fund
As
Copromotor
01 October 2022 → 31 October 2023
Analyzing the immunobiological function of circulating bacterial extracellular vesicles in cancer patients
Fellow: Amélie Vander Cruyssen
Funding: Regional and community funding: Special Research Fund
01 May 2022 → 30 April 2026
A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapies
Funding: Research Foundation - Flanders (FWO)
01 November 2019 → 31 October 2023
Cancer invasion and metastasis: development of a new spheroid confrontation assay and preclinical characterisation of a novel inhibitory mechanism
Fellow: Christophe Mangodt
Funding: Research Foundation - Flanders (FWO)
01 October 2014 → 14 October 2018
Design and development of new selective HDAC6 inhibitors with applications in cancer therapy
Fellows: Yves Depetter
Funding: Regional and community funding: Special Research Fund
01 January 2021 → 31 December 2024
Development and implementation of analytical methods based on laser ablation – and single-event ICP-mass spectrometry for examining metal(loid) signatures in cancer
Funding: Research Foundation - Flanders (FWO)
01 November 2023 → 31 October 2027
Evaluating the potential of Multidrug Adjunctive Cancer Treatment (MDACT) in glioblastoma
Fellow: Thibault Lootens
Funding: Research Foundation - Flanders (FWO)
01 October 2013 → 30 September 2017
Exosome staging to predict axillary lymph node metastasis in early breast cancer.
Funding: Funding by bilateral agreement (private and foundations)
01 November 2022 → 31 October 2026
Exploring the biology of bacterial extracellular vesicles in human biofluids.
Fellow: Niké Guilbert
Funding: Research Foundation - Flanders (FWO)
01 December 2020 → 30 November 2022
Field-flow fractionation (FFF) system for combination with high-end ICP-mass spectrometry (ICP-MS).
Funding: Regional and community funding: Special Research Fund
01 January 2019 → 31 December 2022
Function and biogenesis of extracellular vesicle subsets in cancer
Funding: Research Foundation - Flanders (FWO)
01 November 2020 → 05 January 2021
Identification of anti-FOLR1 VHHs as novel candidates for FOLR1-targeted (brain) tumor imaging and anti-cancer therapy.
Fellow: Katrien Vanderheyden
Funding: Research Foundation - Flanders (FWO)
15 June 2012 → 30 June 2016
IVIS Lumina II Bioluminescence camera for laboratory animal research
Funding: Regional and community funding: Special Research Fund
01 May 2024 → 30 April 2028
Photolithographic DNA printer for massively parallel synthesis of DNA oligonucleotides for spatial - omics and hybrid capture target enrichment applications
Funding: Research Foundation - Flanders (FWO)
01 November 2022 → 31 December 2022
Single-cell ICP-mass spectrometry in the biological sciences: on the way to real-world use
Fellow: Eduardo Bolea Fernandez
Funding: Research Foundation - Flanders (FWO)
01 May 2020 → 30 April 2024
Stimulated emission depletion microscopy (STED): Nanoscopy for innovative research in the life sciences
Funding: Research Foundation - Flanders (FWO)
01 January 2008 → 31 December 2010
Study of fibroblast stromagenesis in a 3-dimensional tissue context
Funding: Research Foundation - Flanders (FWO)
01 October 2019 → 31 October 2022
Temporally and spatially resolved multi-element information at the micro- and nano-scale: development of new analytical methods and their application to metallomics and nanotechnology
Fellow: Eduardo Bolea Fernandez
Funding: Research Foundation - Flanders (FWO)
01 October 2012 → 30 September 2018
The formation of metastases is the main cause of cancer-related mortality
Fellows: Bart Roman
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 May 2022 → 30 April 2026
Ultrafast-scanning tandem ICP-mass spectrometer for interference-free and highly-sensitive transient signal monitoring
Funding: Research Foundation - Flanders (FWO)
01 May 2024 → 30 April 2028
Upgrade of confocal FLIM microscope with two-photon excitation and detection modules
Funding: Research Foundation - Flanders (FWO)
01 May 2022 → 30 April 2026
White light laser-based confocal fluorescence lifetime imaging microscope for multi-parameter 3D live imaging
Funding: Research Foundation - Flanders (FWO)
As
Fellow
01 February 2015 → 31 January 2020
BOF-ZAP professorship in cancer research
Fellows: Olivier De Wever
Funding: Regional and community funding: Special Research Fund
01 January 2013 → 31 December 2015
Resistance to EGFR-targeted therapy in colorectal cancer: biological significance of stromal-derived neuregulin-1
Fellow: Olivier De Wever
Funding: Research Foundation - Flanders (FWO)
01 October 2008 → 30 September 2011
Role of tumor based cancer cell
Fellow: Olivier De Wever
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)